QRG Capital Management Inc. Boosts Stock Position in Corteva, Inc. $CTVA

QRG Capital Management Inc. lifted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 23.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 73,038 shares of the company’s stock after purchasing an additional 13,886 shares during the period. QRG Capital Management Inc.’s holdings in Corteva were worth $6,114,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC grew its stake in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP raised its stake in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after acquiring an additional 16,644 shares during the period. EverSource Wealth Advisors LLC raised its stake in Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after acquiring an additional 980 shares during the period. Cresset Asset Management LLC lifted its holdings in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC purchased a new stake in Corteva during the second quarter valued at about $1,464,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Trading Down 0.2%

Shares of Corteva stock opened at $85.63 on Monday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.95. The firm has a market cap of $57.27 billion, a PE ratio of 50.37, a PEG ratio of 2.62 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a 50 day simple moving average of $79.80 and a two-hundred day simple moving average of $76.94.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the topic of several research reports. Argus boosted their price target on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. The Goldman Sachs Group raised their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Rothschild & Co Redburn boosted their target price on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada increased their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $88.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.